Robin H. Bogner

Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis

Sharad B. Murdande, Michael J. Pikal, Ravi Shanker et al. · Journal of Pharmaceutical Sciences · 2009 · 382 citations

Engineering, Analytical Chemistry, Thermodynamics +5

Solubility Advantage of Amorphous Pharmaceuticals: II. Application of Quantitative Thermodynamic Relationships for Prediction of Solubility Enhancement in Structurally Diverse Insoluble Pharmaceuticals

Sharad B. Murdande, Michael J. Pikal, Ravi Shanker et al. · Pharmaceutical Research · 2010 · 198 citations

Engineering, Physicochemical Analysis, Solubility Enhancement +10

Formation of Physically Stable Amorphous Drugs by Milling with Neusilin

Manish Gupta, Adam L. VanWert, Robin H. Bogner · Journal of Pharmaceutical Sciences · 2003 · 176 citations

Materials Science, Materials Engineering, Engineering +6

Determination of calcium salt solubility with changes in pH and PCO2, simulating varying gastrointestinal environments

Sandra Goss, Karen A Lemons, Jane E. Kerstetter et al. · Journal of Pharmacy and Pharmacology · 2007 · 146 citations · Full text

Food Chemistry, Many Calcium Salts, Engineering +14

Amorphization of Indomethacin by Co-Grinding with Neusilin US2: Amorphization Kinetics, Physical Stability and Mechanism

Deepak Bahl, Robin H. Bogner · Pharmaceutical Research · 2006 · 137 citations

Materials Science, Physical Stability, Engineering +5